Monoclonal antibody treatment shown to provide protection against Marburg, Ravn viruses in nonhuman primates
According to a new study funded by the National Institutes of Health, a monoclonal antibody treatment, MR191-N, successfully protected nonhuman primates against both the Marburg and Ravn viruses even when administered five days after infection. The study was conducted by … Read More